Modernatx, INC.
biotechnology company
Based in MA
AI Overview
With $865K in lobbying spend across 21 quarterly filings, Modernatx, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $120K |
| 2022 | $180K |
| 2023 | $180K |
| 2024 | $185K |
| 2025 | $200K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Modernatx, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
education around potential COVID 19 vaccines and related issues
Issues related to COVID 19 vaccines, mRNA drug discovery, drug development and related issues.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.